Search

Thirty stock type geldings (15 ± 3 y; 556 ± 63 kg BW) were used in a randomized complete design for a 28-d trial to evaluate the influence of cannabidiol (CBD) oil supplementation on health of mature horses by conducting a blood chemistry panel and evaluating the presence of banned substances. Horses were stratified by BW and age, and randomly assigned to 1 of 3 dietary treatments formulated with canola oil to provide.50 mg CBD/kg BW (TRT1; n = 10), 0.75 mg CBD/kg BW (TRT2; n = 10), or 0.00 mg CBD/kg BW (canola oil; CON; n = 10) only as determined by manufacturer (Arrowhead Labs). Treatments were individually fed and top-dressed onto a commercially available concentrate twice daily at 12 h intervals using attachable feed bags. Diets were formulated to meet or slightly exceed nutritional requirements for mature horses at maintenance. Between meals, horses were maintained in adjacent dry lots and received coastal bermudagrass hay ad libitum. Body weight was obtained, and body condition scores (BCS) were assigned every4 d. On d 0 and 28, blood was collected via jugular venipuncture and serum was harvested to perform a blood chemistry panel and drugs of abuse screening at the Texas Veterinary Medical Diagnostic Laboratory (TVMDL; College Station, TX). Data were analyzed using PROC MIXED of SAS (v9.4), and the model included treatment, time, and the treatment × time interaction for BW and BCS. Blood chemistry variables on d 0 were used as a covariate and the main effect tested was treatment. Linear and quadratic orthogonal polynomial contrasts were used to partition sum of squares. Analysis of supplement samples revealed supplemented products contained lower CBD concentrations then indicated from initial testing. Therefore, horses in TRT1 and TRT2 received an average of 0.13 mg CBD/kg and 0.12 mg CBD/kg BW, respectively. Dietary treatments did not affect concentrate intake, BW, or BCS. Supplementation of CBD did not result in the presence of any banned substances in serum, including CBD, 7-carboxycannabidiol, 7-Nor-7-carboxycannabidiol, and tetrahydrocannabinol (THC). Following 28 d of supplementation, gamma-glutamyl transferase (GGT) responded quadratically (P = 0.06) to treatment, with a peak in GGT in horses receiving TRT2. Serum creatinine concentration tended (P = 0.06) to decrease with increasing inclusion of CBD in the diet. In contrast, the main effect of treatment on Ca concentrations was linear (P = 0.01) and characterized by decreased Ca values for TRT1 compared with TRT2 and CON. Canola based CBD oil was well-accepted by mature horses, banned substances were not detectible in blood, and blood chemistry parameters were not adversely affected as a result of supplementation; however, more information is needed to improve stability of CBD used in dietary products.

To determine the effectiveness of a digital interactive multimedia tutorial (DIMT) for preparing veterinary students to perform ultrasonography in horses.42 third-year veterinary students.Students were randomly assigned to 3 instructional methods: independent study (ie, 45 minutes to read a highlighted textbook chapter), lecture (ie, 45-minute lecture by a faculty member), or digital interactive multimedia tutorial (DIMT; ie, 45-minute narrated, interactive module). Written and practical tests were administered after each instruction session. For the practical test, each student was required to obtain a series of ultrasound images of a live horse, and images were later scored for quality by an individual unaware of the instructional method used.Higher-quality ultrasound images were obtained by veterinary students who had reviewed the DIMT rather than the analogous information in textbook chapters. No difference in scores was identified between students in the lecture group and those in the DIMT group. Students' perceptions suggested that practical instruction facilitated by clinicians was a key component of learning how to perform ultrasonography in horses.Results supported the use of DIMTs in preparing veterinary students to perform ultrasonography in horses.

Objective To determine the influence of epidural detomidine and morphine on serum corticosteroid concentrations and pain-related behavioral responses in mares during and after ovariectomy via colpotomy. Study design Blinded prospective study. Animals Nine university-owned mares. Methods Five of 9 horses received caudal epidural detomidine hydrochloride (0.01 mg/kg) and morphine sulfate (0.1 mg/kg) prior to surgery. All horses received local anesthetic around the ovarian pedicle, 0.02 mg/kg butorphanol IV at the start of the procedure and after first ovary removal, were sedated as required throughout the procedure, and were monitored for leg lifting, grunting, and abdominal tensing. Horses were monitored hourly for pain postoperatively. Heart rate was recorded every 4 hours, and photographs were taken to assess pain according to the horse grimace scale (HGS). Control group horses (n = 4) were treated with butorphanol (0.02 mg/kg IV) every 4 hours for 24 hours postoperatively. All horses received oral phenylbutazone 18 hours postoperatively. Serum cortisol was measured prior to the procedure, after first and second ovary removal, and 8 and 24 hours postoperatively. Results No differences were detected between horses receiving caudal epidural detomidine and morphine and those that received systemic opioids. A decrease in HGS score occurred after phenylbutazone administration. Conclusion Administration of caudal epidural detomidine and morphine resulted in similar pain-related behavior and corticosteroid concentrations as did administration of systemic butorphanol every 4 hours for 24 hours postoperatively. Clinical significance Caudal epidural detomidine and morphine may mitigate the requirement for frequent systemic opioid administration after a potentially painful procedure.

OBJECTIVE To describe the signalment, clinical features, and outcome for male horses with urethral rents following perineal urethrotomy (PU) or corpus spongiotomy (CS). DESIGN Retrospective case series. ANIMALS 33 horses. PROCEDURES Medical records of male horses examined because of hematuria or hemospermia caused by urethral rents that underwent PU or CS at a referral hospital between 1989 and 2013 were reviewed. Data regarding signalment, clinical features, urethroscopic findings, surgical treatment, and outcome were recorded. Long-term follow-up information was obtained by telephone interviews. RESULTS Age of the study population ranged from 3 to 18 years. Nineteen geldings and 1 stallion were examined because of hematuria, of which 13 and 7 underwent PU and CS, respectively, at a mean of 56 days after onset of clinical signs. Thirteen stallions were examined because of hemospermia, of which 7 and 6 underwent PU and CS, respectively, at a mean of 193 days after onset of clinical signs. Hematuria resolved following 1 surgical procedure in all 17 horses for which long-term information was available. Of the 12 stallions for which long-term information was available, 7 had resolution of hemospermia after 1 PU or CS and 5 developed recurrent hemospermia that required additional PUs or CSs (n = 3) or primary closure of the urethral rent (2). CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that PU and CS were reliable treatments for resolution of hematuria in male horses with urethral rents; stallions with urethral rents may require multiple PUs or CSs or primary closure of the rent for resolution of hemospermia.